Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

TNF-alpha inhibitors can cause various immune-related skin issues.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Some drugs used to treat immune conditions may cause different types of hair loss.

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Leflunomide is more likely to help treat alopecia areata than cause it.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.